Credit: Courtesy of Anup Sharma and Nita Ahuja, Johns Hopkins
Colon cancer cell lines, named SW480 and HT29, used in laboratory experiments to explore how the epigenetic drug 5-azacitidine may improve the cancer cell killing potential of the chemotherapy drug Irinotecan. Insets show a magnified image of the cell lines.